IP Library Granted Patent US 7,811,608
Granted Patent B2
US 7,811,608 · App. 11/459,972 · Granted Oct 12, 2010

Tissue repair compositions and methods for their manufacture and use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,811,608
App. No.
11/459,972
Granted
Oct 12, 2010
Kind
B2
Abstract

An osteogenic composition is prepared by a process including the steps of subjecting demineralized bone to an extraction medium to produce an insoluble extraction product and a soluble extraction product, separating the insoluble extraction product and the soluble extraction product, drying the soluble extraction product to remove all or substantially all of the moisture in the soluble extracting product, and combining the dried soluble extraction product with demineralized bone particles. Preferably, the process does not involve heating.

Claims (20)

1. An osteogenic composition comprising: demineralized bone particles enriched with dried, acid-soluble, demineralized bone extraction product derived from demineralized bone contacted with an acidic extraction medium at a pH of between 0.5 and 5.5 and at an extraction temperature between about 15° C. and 25° C.; and

a thickening material selected from the group consisting of collagen, insoluble extraction product, calcium phosphate, hydroxyapatite, tricalcium phosphate, biphasic calcium phosphate, calcium sulfate, biological glass, natural polymer, synthetic polymer, poloxamer, and reverse phase medium.

2. The osteogenic composition of claim 1 , further comprising a bone morphogenetic protein.

3. The osteogenic composition of claim 1 , further comprising an active ingredient selected from the group consisting of bone morphogenetic protein, cartilage derived morphogenetic protein, cortical bone, cancellous bone, bone mineral, osteogenic chemical, osteogenic peptide, osteogenic growth factor, recombinant bone morphogenetic protein, fibronectin, blood, bone marrow and blood-derived protein.

4. The composition of claim 1 , wherein said dried, acid-soluble, demineralized bone extraction product is a white, fluffy substance.

5. The composition of claim 1 , wherein said dried, acid-soluble, demineralized bone extraction product is further combined with ethanol or water, and an active ingredient selected from the group consisting of bone morphogenetic protein, cartilage derived morphogenetic protein, cortical bone, cancellous bone, bone mineral, osteogenic chemical, osteogenic peptide, osteogenic growth factor, recombinant bone morphogenetic protein, fibronectin, blood, bone marrow and blood-derived protein.

6. The composition of claim 5 , wherein the product is further dried after combining with said ethanol or water and said active ingredient.

7. The composition of claim 6 , wherein said product is dried by lyophilization.

8. The composition of claim 1 , wherein the form of said composition is selected from the group consisting of gel, paste, putty and sponge.

9. An osteogenic composition comprising a dried, acid-soluble extraction product derived from demineralized bone contacted with extraction medium at a pH of between 0.5 and 5.5 and at an extraction temperature between about 15° C. and 25° C. and further including a reverse phase medium.

10. An osteogenic composition comprising a dried, acid-soluble extraction product derived from demineralized bone contacted with extraction medium at a pH of between 0.5 and 5.5 and at an extraction temperature between about 15° C. and 25° C.

11. An osteogenic composition comprising a dried, acid-soluble extraction product derived from demineralized bone contacted with extraction medium at a pH of between 0.5 and 5.5 and at an extraction temperature between about 15° C. and 25° C. and further including demineralized bone particles.

12. The osteogenic composition of claim 9 further including demineralized bone.

13. The osteogenic composition of claim 9 further including cancellous bone.

14. The osteogenic composition of claim 9 further including bone marrow.

15. The osteogenic composition of claim 10 further including cancellous bone.

16. The osteogenic composition of claim 10 further including bone marrow.

17. An osteogenic composition comprising: demineralized bone particles enriched with dried, acid-soluble, demineralized bone extraction product derived from demineralized bone contacted with extraction medium at a pH of between 0.5 and 5.5 and at an extraction temperature between about 15° C. and 25° C.; and collagen.

18. An osteogenic composition comprising: demineralized bone particles enriched with dried, acid-soluble, demineralized bone extraction product derived from demineralized bone contacted with extraction medium at a pH of between 0.5 and 5.5 and at an extraction temperature between about 15° C. and 25° C.; collagen and tricalcium phosphate.

19. An osteogenic composition comprising: demineralized bone particles enriched with dried, acid-soluble, demineralized bone extraction product derived from demineralized bone contacted with extraction medium at a pH of between 0.5 and 5.5 and at an extraction temperature between about 15° C. and 25° C.; collagen, tricalcium phosphate and reverse phase medium.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Nov 12, 2024
From: BLUE TORCH FINANCE LLC
To: ISOTIS ORTHOBIOLOGICS, INC.; ORTHOFIX US, LLC; SEASPINE, INC.; SEASPINE ORTHOPEDICS CORPORATION; SPINAL KINETICS LLC; THEKEN SPINE, LLC
Reel/Frame 069358/0110 →
RELEASE OF SECURITY INTEREST Recorded Nov 7, 2024
From: JPMORGAN CHASE BANK, N.A.
To: SEASPINE ORTHOPEDICS CORPORATION; SEASPINE, INC.; ISOTIS ORTHOBIOLOGICS, INC.; THEKEN SPINE, LLC
Reel/Frame 069323/0561 →
SECURITY INTEREST Recorded Jan 10, 2024
From: ISOTIS ORTHOBIOLOGICS, INC.
To: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 066258/0555 →
SECURITY INTEREST Recorded Feb 21, 2023
From: SEASPINE ORTHOPEDICS CORPORATION; SEASPINE, INC.; ISOTIS ORTHOBIOLOGICS, INC.; THEKEN SPINE, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE ASSISTANT
Reel/Frame 062819/0650 →
RELEASE OF SECURITY INTEREST Recorded Jan 9, 2023
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: SEASPINE HOLDINGS CORPORATION; SEASPINE ORTHOPEDICS CORPORATION; SEASPINE, INC.; ISOTIS, INC.; SEASPINE SALES LLC; ISOTIS ORTHOBIOLOGICS, INC.; THEKEN SPINE, LLC; SEASPINE ORTHOPEDICS INTERMEDIATECO, INC.; 7D SURGICAL USA INC.
Reel/Frame 062336/0593 →
SECOND AMENDMENT TO PATENT SECURITY AGREEMENT Recorded Jul 18, 2022
From: SEASPINE HOLDINGS CORPORATION; SEASPINE ORTHOPEDICS CORPORATION; SEASPINE, INC.; ISOTIS, INC.; SEASPINE SALES LLC; ISOTIS ORTHOBIOLOGICS, INC.; THEKEN SPINE, LLC; SEASPINE ORTHOPEDICS INTERMEDIATECO, INC.; 7D SURGICAL USA INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 060715/0395 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2018
From: KAY, JOHN F.; BORDEN, MARK; COULSON, RICHARD; KING, EDWARD
To: GENSCI ORTHOBIOLOGICS, INC.
Reel/Frame 047123/0569 →
CHANGE OF NAME Recorded Oct 10, 2018
From: GENSCI ORTHOBIOLOGICS, INC.
To: ISOTIS ORTHOBIOLOGICS, INC.
Reel/Frame 047211/0740 →
SECURITY INTEREST Recorded Dec 28, 2015
From: SEASPINE HOLDINGS CORPORATION; SEASPINE ORTHOPEDICS CORPORATION; SEASPINE, INC.; ISOTIS, INC.; SEASPINE SALES LLC; ISOTIS ORTHOBIOLOGICS, INC.; THEKEN SPINE, LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 037393/0895 →